Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Erik Michael Rasmussen is active.

Publication


Featured researches published by Erik Michael Rasmussen.


Journal of Clinical Microbiology | 2013

Can Molecular Methods Detect 1% Isoniazid Resistance in Mycobacterium tuberculosis?

Dorte Bek Folkvardsen; Erik Svensson; Vibeke Østergaard Thomsen; Erik Michael Rasmussen; Didi Bang; Jim Werngren; Sven Hoffner; Doris Hillemann; Leen Rigouts

ABSTRACT Patients may harbor both drug-susceptible and -resistant bacteria, representing heteroresistance. We studied mixtures of isoniazid-resistant and -susceptible Mycobacterium tuberculosis strains. Conventional drug susceptibility testing was the most sensitive method of detection, whereas the line probe assay and sequencing were not able to detect the clinically relevant 1% proportion of resistant bacteria.


Journal of Clinical Microbiology | 2013

Rifampin Heteroresistance in Mycobacterium tuberculosis Cultures as Detected by Phenotypic and Genotypic Drug Susceptibility Test Methods

Dorte Bek Folkvardsen; Vibeke Østergaard Thomsen; Leen Rigouts; Erik Michael Rasmussen; Didi Bang; Gertjan Bernaerts; Jim Werngren; Juan Carlos Toro; Sven Hoffner; Doris Hillemann; Erik Svensson

ABSTRACT Tuberculosis patients may harbor both drug-susceptible and -resistant bacteria, i.e., heteroresistance. We used mixtures of rifampin-resistant and -susceptible Mycobacterium tuberculosis strains to simulate heteroresistance in patient samples. Molecular tests can be used for earlier discovery of multidrug resistance (MDR), but the sensitivity to detect heteroresistance is unknown. Conventional phenotypic drug susceptibility testing was the most sensitive, whereas two line probe assays and sequencing were unable to detect the clinically important 1% resistant bacteria.


Emerging Infectious Diseases | 2017

Mycobacterium chimaera in Heater–Cooler Units in Denmark Related to Isolates from the United States and United Kingdom

Erik Svensson; Elsebeth Tvenstrup Jensen; Erik Michael Rasmussen; Dorte Bek Folkvardsen; Anders Norman; Troels Lillebaek

Mycobacterium chimaera was present at high rates (>80%) in heater–cooler units (HCUs) from all 5 thoracic surgery departments in Denmark. Isolates were clonal to HCU-associated isolates from the United States (including some from patients) and United Kingdom. However, M. chimaera from 2 brands of HCU were genetically distinct.


Proceedings of the National Academy of Sciences of the United States of America | 2016

Armed conflict and population displacement as drivers of the evolution and dispersal of Mycobacterium tuberculosis

Vegard Eldholm; John H.-O. Pettersson; Ola Brønstad Brynildsrud; Andrew Kitchen; Erik Michael Rasmussen; Troels Lillebaek; Janne O. Rønning; Valeriu Crudu; Anne Torunn Mengshoel; Nadia Debech; Kristian Alfsnes; Jon Bohlin; Caitlin S. Pepperell; Francois Balloux

Significance We used population genomic analyses to reconstruct the recent history and dispersal of a major clade of Mycobacterium tuberculosis in central Asia and beyond. Our results indicate that the fall of the Soviet Union and the ensuing collapse of public health systems led to a rise in M. tuberculosis drug resistance. We also show that armed conflict and population displacement is likely to have aided the export of this clade from central Asia to war-torn Afghanistan and beyond. The “Beijing” Mycobacterium tuberculosis (Mtb) lineage 2 (L2) is spreading globally and has been associated with accelerated disease progression and increased antibiotic resistance. Here we performed a phylodynamic reconstruction of one of the L2 sublineages, the central Asian clade (CAC), which has recently spread to western Europe. We find that recent historical events have contributed to the evolution and dispersal of the CAC. Our timing estimates indicate that the clade was likely introduced to Afghanistan during the 1979–1989 Soviet–Afghan war and spread further after population displacement in the wake of the American invasion in 2001. We also find that drug resistance mutations accumulated on a massive scale in Mtb isolates from former Soviet republics after the fall of the Soviet Union, a pattern that was not observed in CAC isolates from Afghanistan. Our results underscore the detrimental effects of political instability and population displacement on tuberculosis control and demonstrate the power of phylodynamic methods in exploring bacterial evolution in space and time.


International Journal of Medical Microbiology | 2016

Substantial molecular evolution and mutation rates in prolonged latent Mycobacterium tuberculosis infection in humans

Troels Lillebaek; Anders Norman; Erik Michael Rasmussen; Rasmus Lykke Marvig; Dorte Bek Folkvardsen; Åse Bengaard Andersen; Lars Jelsbak

The genome of Mycobacterium tuberculosis (Mtb) of latently infected individuals may hold the key to understanding the processes that lead to reactivation and progression to clinical disease. We report here analysis of pairs of Mtb isolates from putative prolonged latent TB cases. We identified two confirmed cases, and used whole genome sequencing to investigate the mutational processes that occur over decades in latent Mtb. We found an estimated mutation rate between 0.2 and 0.3 over 33 years, suggesting that latent Mtb accumulates mutations at rates similar to observations from cases of active disease.


Journal of Clinical Microbiology | 2013

Mycobacterium tuberculosis Outbreak Strain of Danish Origin Spreading at Worrying Rates among Greenland-Born Persons in Denmark and Greenland

Troels Lillebaek; Åse Bengård Andersen; Erik Michael Rasmussen; Zaza Kamper-Jørgensen; M K Pedersen; K Bjorn-Mortensen; K Ladefoged; Vibeke Østergaard Thomsen

ABSTRACT Transmission of Mycobacterium tuberculosis continues at high rates among Greenland-born persons in Greenland and Denmark, with 203 and 450 notified cases per 105 population, respectively, in the year 2010. Here, we document that the predominant M. tuberculosis outbreak strain C2/1112-15 of Danish origin has been transmitted to Greenland-born persons in Denmark and subsequently to Greenland, where it is spreading at worrying rates and adding to the already heavy tuberculosis burden in this population group. It is now clear that the C2/1112-15 strain is able to gain new territories using a new population group as the “vehicle.” Thus, it might have the ability to spread even further, considering the potential clinical consequences of strain diversity such as that seen in the widely spread Beijing genotype. The introduction of the predominant M. tuberculosis outbreak strain C2/1112-15 into the Arctic circumpolar region is a worrying tendency which deserves attention. We need to monitor whether this strain already has, or will, spread to other countries.


Infection and Immunity | 2015

Differential Influence of Nutrient-Starved Mycobacterium tuberculosis on Adaptive Immunity Results in Progressive Tuberculosis Disease and Pathology

Jes Dietrich; Sugata Roy; Ida Rosenkrands; Thomas Lindenstrøm; Jonathan Filskov; Erik Michael Rasmussen; Joseph P. Cassidy; Peter Andersen

ABSTRACT When infected with Mycobacterium tuberculosis, most individuals will remain clinically healthy but latently infected. Latent infection has been proposed to partially involve M. tuberculosis in a nonreplicating stage, which therefore represents an M. tuberculosis phenotype that the immune system most likely will encounter during latency. It is therefore relevant to examine how this particular nonreplicating form of M. tuberculosis interacts with the host immune system. To study this, we first induced a state of nonreplication through prolonged nutrient starvation of M. tuberculosis in vitro. This resulted in nonreplicating persistence even after prolonged culture in phosphate-buffered saline. Infection with either exponentially growing M. tuberculosis or nutrient-starved M. tuberculosis resulted in similar lung CFU levels in the first phase of the infection. However, between week 3 and 6 postinfection, there was a very pronounced increase in bacterial levels and associated lung pathology in nutrient-starved-M. tuberculosis-infected mice. This was associated with a shift from CD4 T cells that coexpressed gamma interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α) or IFN-γ, TNF-α, and interleukin-2 to T cells that only expressed IFN-γ. Thus, nonreplicating M. tuberculosis induced through nutrient starvation promotes a bacterial form that is genetically identical to exponentially growing M. tuberculosis yet characterized by a differential impact on the immune system that may be involved in undermining host antimycobacterial immunity and facilitate increased pathology and transmission.


Scandinavian Journal of Immunology | 2011

Combined IL-12 receptor and IgA deficiency in an adult man intestinally infested by an unknown, non-cultivable mycobacterium.

Lone Schejbel; Erik Michael Rasmussen; Helle Bruunsgaard Kemp; Ann-Charlotte Lundstedt; Kári R Nielsen; Niels Obel; Hanne Vibeke Marquart; Åse Bengård Andersen

Interleukin‐12 receptor deficiency is a well‐described cause of human susceptibility to infection with low‐virulent mycobacteria and Salmonella species. We identified a male patient presenting in his late forties with severe gastroenteropathy because of outbred infestation by a previously unknown mycobacterium. In addition to selective IgA deficiency, the patient was found to carry a not previously described R283X homozygous mutation in his IL12RΒ1 gene. Two of his sisters, a brother, and his four children were healthy, heterozygous carriers of the mutation. In this patient, the combination of two deficiencies could promote illness. Even though the IgA deficiency in itself does not predispose to mycobacterial disease, the lack of secreted IgA may have disturbed the intestinal homoeostasis and increased the susceptibility to the low‐virulent mycobacterium that the patient was not able to clear because of his IL12R deficiency. Antimycobacterial chemotherapy and interferon‐γ treatment for 2 years significantly improved his condition. This is the first description of IL12RΒ1 deficiency combined with another immunodeficiency, and we suggest that combinatory defects may circumvent the otherwise low penetrance of IL12RB1 deficiency.


Scandinavian Journal of Infectious Diseases | 2011

Is sarcoidosis a rickettsiosis? An archival study

Claus Bo Svendsen; Nils Milman; Claus B. Andersen; Erik Michael Rasmussen; Vibeke Østergaard Thomsen; Karen A. Krogfelt

Abstract Background: Based on earlier research, Rickettsia helvetica could possibly be involved in the pathogenesis of sarcoidosis. Rickettsiae are transmitted to humans by a tick vector, Ixodes ricinus; this tick is highly prevalent in Northern Europe. We aimed to investigate the association between evidence of rickettsiae and sarcoidosis in histological samples. Methods: We included formalin-fixed, paraffin-embedded mediastinal lymph node biopsies from 52 ethnic Danish patients with sarcoidosis and compared these with 50 biopsies from ethnic Danish patients with mediastinal lymphadenopathy of other causes. Samples were analysed for: (1) rickettsial DNA by real-time polymerase chain reaction (PCR) and (2) rickettsial rDNA (ribosomal DNA) by a specific fluorescence in situ hybridization technique (FISH). Results: Rickettsia was not detected in biopsies by real-time PCR and/or FISH analyses. Conclusion: Our results do not support the hypothesis that Rickettsia is involved in the pathogenesis of sarcoidosis.


Clinical Respiratory Journal | 2011

The continuing search for Mycobacterium tuberculosis involvement in sarcoidosis: a study on archival biopsy specimens

Claus Bo Svendsen; Nils Milman; Erik Michael Rasmussen; Vibeke Østergaard Thomsen; Claus B. Andersen; Karen A. Krogfelt

Introduction:  Increasing evidence indicates that mycobacteria may be involved in the aetiology and pathophysiology of sarcoidosis.

Collaboration


Dive into the Erik Michael Rasmussen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anders Norman

Technical University of Denmark

View shared research outputs
Top Co-Authors

Avatar

Didi Bang

Statens Serum Institut

View shared research outputs
Top Co-Authors

Avatar

Åse Bengård Andersen

Copenhagen University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lars Jelsbak

Technical University of Denmark

View shared research outputs
Top Co-Authors

Avatar

Claus B. Andersen

Copenhagen University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge